ເຫັດກ້ານຈອງ / Lizing Mushroom

Use
Food
Income
Medicine
Scientific Name / Family
Ganoderma lucidum (Curtis) P. Karst. / Ganodermataceae
Synonyms
Scindalma japonicum (Fr.) Kuntze
Polyporus lucidus (Curtis) Fr.
Grifola lucida (Curtis) Gray
Phaeoporus lucidus (Curtis) J. Schröt.
Fomes lucidus (Curtis) Sacc.
Boletus lucidus Curtis
Other Names
Chinese: reishi mushroom, lingzhi
Thai: hlin cheu
Vietnamese: linh chi
Botanical Description

Fruiting body (basidioma) annual, sessile to long mesopode or pleuropode depending on which substratum it is produced, either tree bole or buried wood, generally thick, up to 20 mm, sometimes more or less tumid when sessile. Cap subplane to very irregular, up to 160 mm across; stipe up to 100−120 mm long, 10−30 mm thick; upper surface and stipe shiny, lacquered, blackish−brown, irregularly humped; margin and pore surface white when growing, tawny with age.

Description of Use

A 2015 Cochrane database review found insufficient evidence to justify the use of G. lucidum as a first−line cancer treatment. It suggests that G. lucidum may have "benefit as an alternative adjunct to conventional treatment in consideration of its potential of enhancing tumour response and stimulating host immunity". Existing studies do not support the use of G. lucidum for treatment of risk factors of cardiovascular disease in people with type 2 diabetes mellitus.(https://en.wikipedia.org/wiki/Lingzhi_mushroom#Taxonomy_and_naming). Ganoderma lucidum produces a group of triterpenes called ganoderic acids, which have a molecular structure similar to steroid hormones. It also contains other compounds often found in fungal materials, including polysaccharides (such as beta−glucan), coumarin, mannitol, and alkaloids. Sterols isolated from the mushroom include, ganoderol, ganoderenic acid, ganoderiol, ganodermanontriol, lucidadiol, and ganodermadiol. Fungal immunomodulatory proteins (FIPs) are bioactive ingredients within genera Ganoderma that have immune building properties.

Contribute